Closed loop control system with safety parameters and methods

Patent metadata

Field	Value
Publication number	US-11083843-B2
Application number	US-201816103060-A
Country	US
Kind code	B2
Filing date	Aug 14, 2018
Priority date	Oct 23, 2007
Publication date	Aug 10, 2021
Grant date	Aug 10, 2021

Abstract

Methods, system and devices for monitoring a plurality of parameters associated with a closed loop control operation including continuously monitoring a physiological condition and automatic administration of a medication, detecting an adverse condition associated with the monitored physiological condition or the medication administration deviating from a predetermined safety level of the closed loop control operation, and initiating a non-zero pre-programmed medication delivery rate are provided.

First claim

The invention claimed is:

1. A method comprising:
monitoring a plurality of parameters associated with a closed loop control operation, including monitoring a sensor signal representative of a glucose level and an administration of a medication;
detecting an onset of an amount of the administration of the medication to be delivered that exceeds a predetermined threshold level;
receiving blood glucose measurement information;
determining whether the sensor signal representative of the glucose level is within a predetermined margin of error based on the received blood glucose measurement information; and
executing the administration of the amount of the medication if the sensor signal representative of the glucose level is within the predetermined margin of error based on the received blood glucose measurement information.

2. The method of claim 1 , wherein the predetermined threshold level is a set highest insulin delivery rate.

3. The method of claim 1 , further comprising detecting a subsequent onset of another amount of the administration of the medication to be delivered that exceeds the predetermined threshold level.

4. The method of claim 1 , further comprising requesting the blood glucose measurement information prior to receiving the blood glucose information.

5. The method of claim 4 , further comprising discontinuing requesting the blood glucose measurement information after a predetermined number of the sensor signals representative of the glucose level are within the predetermined margin of error based on the received blood glucose measurement information.

6. The method of claim 1 , further comprising a control unit including one or more processors having instructions for the steps of monitoring, detecting, receiving, determining, and executing.

7. The method of claim 6 , wherein the control unit comprises a Kalman filter.

8. The method of claim 1 , further comprising determining the sensor signal representative of the glucose level using a continuous glucose sensor.

9. The method of claim 1 , further comprising executing the administration of the medication using a medication delivery device.

10. The method of claim 9 , wherein the medication delivery device is an external infusion pump, an implantable infusion pump, or an on-body patch pump.

11. A method comprising:
monitoring a plurality of parameters associated with a closed loop control operation, including monitoring a sensor signal representative of a glucose level and an administration of a medication;
detecting an onset of an amount of the administration of the medication to be delivered that exceeds a predetermined threshold level;
receiving blood glucose measurement information;
determining whether the sensor signal representative of the glucose level is within a predetermined margin of error based on the received blood glucose measurement information;
retrieving the plurality of parameters if the sensor signal representative of the glucose level is not within the predetermined margin of error based on the received blood glucose measurement information;
evaluating the retrieved plurality of parameters based on the received blood glucose measurement information; and
modifying the plurality of parameters based on the evaluation.

12. The method of claim 11 , wherein the predetermined threshold level is a set highest insulin delivery rate.

13. The method of claim 11 , further comprising detecting a subsequent onset of another amount of the administration of the medication to be delivered that exceeds the predetermined threshold level.

14. The method of claim 11 , further comprising requesting the blood glucose measurement information prior to receiving the blood glucose information.

15. The method of claim 14 , further comprising discontinuing requesting the blood glucose measurement information after a predetermined number of the sensor signals representative of the glucose level are within the predetermined margin of error based on the received blood glucose measurement information.

16. The method of claim 11 , further comprising repeating the steps of detecting, receiving, and determining based on the modified plurality of parameters, and executing the administration of the amount of the medication if the sensor signal representative of the glucose level is within the predetermined margin of error based on the received blood glucose measurement information.

17. The method of claim 11 , further comprising a control unit including one or more processors having instructions for the steps of monitoring, detecting, receiving, determining, retrieving, evaluating, and modifying.

18. The method of claim 17 , wherein the control unit comprises a Kalman filter.

19. The method of claim 11 , wherein the retrieved plurality of parameters are selected from a request for an additional blood glucose measurement value, an instruction to modify or adjust insulin delivery rate, a command to disable the closed loop control operation and initiate a semi-closed loop control operation, a command to disable the closed loop control operation and initiate a manual control operation, and an instruction to recalibrate the sensor signal.

20. The method of claim 11 , further comprising determining the sensor signal representative of the glucose level using a continuous glucose sensor.

Assignees

• Abbott Diabetes Care Inc

Inventors

• Hayter Gary Alan
• Taub Marc Barry
• Bernstein Daniel Milfred
• Sloan Mark Kent

Classifications

• A61B5/4839

  combined with drug delivery · CPC title

• G16H40/63

  for local operation · CPC title

• A61B5/7221

  Determining signal validity, reliability or quality (preventing, reducing or removing noise induced by motion artefacts A61B5/7207; noise originating from a therapeutic or surgical apparatus A61B5/7217) · CPC title

• A61M2005/14208

  with a programmable infusion control system, characterised by the infusion program · CPC title

• G16H20/17

  delivered via infusion or injection · CPC title